In the pharmaceutical industry, the journey from discovery to finished drug product relies heavily on a robust supply of high-quality chemical intermediates. 2-Bromo-4'-Benzyloxy-3'-nitroacetophenone, identified by its CAS number 43229-01-2, is a prime example of such a critical intermediate. For procurement managers and R&D scientists, understanding its role and how to source it effectively is paramount to ensuring the timely and successful development of life-saving medications.

Understanding CAS 43229-01-2: Chemical Profile and Significance

2-Bromo-4'-Benzyloxy-3'-nitroacetophenone is an organic compound with the molecular formula C15H11BrNO4. Its structure features a brominated acetophenone backbone, incorporating a benzyloxy group and a nitro group. This specific arrangement of functional groups makes it a versatile reactant in organic synthesis. Its primary significance lies in its application as a precursor for APIs, most notably in the synthesis pathway for Arformoterol Tartrate, a bronchodilator used in the treatment of COPD. The demand for such intermediates is driven by the global need for effective respiratory therapies, making reliable supply chains for CAS 43229-01-2 essential.

Why Buyers Need High-Purity Intermediates

For pharmaceutical applications, the purity of intermediates is non-negotiable. 2-Bromo-4'-Benzyloxy-3'-nitroacetophenone is typically required at a purity level of 99% or higher. Impurities can lead to:

• Reduced reaction yields: Leading to increased production costs and waste.
• Formation of unwanted byproducts: Requiring additional purification steps and potentially impacting the final API's quality.
• Compromised efficacy and safety of the final drug: Which can have severe regulatory and patient health implications.

Therefore, when looking to buy CAS 43229-01-2, buyers must prioritize suppliers who can consistently deliver material that meets stringent purity standards and provide comprehensive analytical documentation.

Key Considerations When Purchasing CAS 43229-01-2:

When engaging with suppliers for this pharmaceutical intermediate, consider the following:

• Supplier Reputation and Reliability: Look for established manufacturers and suppliers with a proven track record in the fine chemical and pharmaceutical intermediate market. Companies that specialize in niche intermediates are often a good starting point.
• Quality Control and Documentation: Ensure the supplier has robust quality control measures. Requesting a Certificate of Analysis (CoA) that details the purity and identity of the compound is standard. Material Safety Data Sheets (MSDS) should also be readily available.
• Manufacturing Location and Capacity: Many efficient manufacturers for such intermediates are located in China. Evaluate their production capacity to ensure they can meet your volume needs, from R&D quantities to commercial batches.
• Pricing and Value: While price is a factor, it should be considered alongside quality and reliability. Obtain quotes from multiple suppliers, but prioritize those offering competitive pricing for high-quality, verified material. Direct manufacturer pricing is often the most advantageous.
• Logistics and Delivery: Understand the supplier's shipping capabilities and lead times. For international buyers, efficient logistics and customs handling are crucial.

Finding the Right Manufacturer/Supplier

To buy CAS 43229-01-2, search for reputable chemical suppliers and manufacturers specializing in pharmaceutical intermediates. Utilize search terms like 'buy CAS 43229-01-2,' 'pharmaceutical intermediate supplier,' or '2-Bromo-4'-Benzyloxy-3'-nitroacetophenone price.' Engage directly with potential suppliers, request product specifications, samples, and quotes to compare their offerings and ensure they meet your requirements.

Conclusion: Strategic Sourcing for Pharmaceutical Success

2-Bromo-4'-Benzyloxy-3'-nitroacetophenone (CAS 43229-01-2) is more than just a chemical compound; it is a critical building block in the pharmaceutical supply chain. By understanding its importance, prioritizing purity, and carefully selecting suppliers based on quality, reliability, and value, pharmaceutical companies can ensure the consistent availability of this essential intermediate, thereby supporting the development and manufacturing of vital medicines.